胱胺 二盐酸盐 CAS 56-17-7

56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl) disulfide dihydrochloride Cystamin dihydrochloride Cystamine hydrochloride 2,2'-Dithio-bis-(ethylamine) dihydrochloride EINECS 200-260-7 NSC 39322 USAF CB-34 Cystamine HCl UNII-I90T518457

纯度 97%+现货药物标准品
CAS 号56-17-7
分子式C4H12N2S2 2*HCl
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

胱胺 二盐酸盐 56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl) disulfide dihydrochloride Cystamin dihydrochloride Cystamine hydrochloride 2,2'-Dithio-bis-(ethylamine) dihydrochloride EINECS 200-260-7 NSC 39322 USAF CB-34 Cystamine HCl UNII-I90T518457 CAS 56-17-7 结构式 Chemical Structure

产品介绍 Description

CAS 56-17-7 对应的胱胺 二盐酸盐（56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl) disulfide dihydrochloride Cystamin dihydrochloride Cystamine hydrochloride 2,2'-Dithio-bis-(ethylamine) dihydrochloride EINECS 200-260-7 NSC 39322 USAF CB-34 Cystamine HCl UNII-I90T518457）为 CATO 佳途药物标准品产品线成员。分子式 C4H12N2S2 2*HCl。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认，质量稳定可溯源。

受分子结构中含硫有机，含氯取代的影响，胱胺 二盐酸盐表现为白色至类白色结晶性粉末。（具有轻微卤代物特征气味，具有氨/胺类微弱气味，含硫化合物特征性气味）。其固体形态的物理化学属性——包括188.73 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。含氮官能团的存在使该化合物在ESI正离子模式下具有优良的离子化效率，适合LC-MS/MS分析。 化学式为 C4H12N2S2 2HCl 的胱胺 二盐酸盐（56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl)

应用场景：针对化学分析用途，胱胺 二盐酸盐（56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl

理化性质 Physical & Chemical Properties

中文名称胱胺 二盐酸盐
分子式C4H12N2S2 2*HCl
分子量188.73 g/mol
外观形态白色至类白色结晶性粉末。（具有轻微卤代物特征气味，具有氨/胺类微弱气味，含硫化合物特征性气味）
纯度97%+
储存条件2-8°C冷藏保存，避光，密闭保存防止挥发
溶解性参考可溶于DMSO、DMF、甲醇
稳定性对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）-1.0
CAS登记年份（估）1957年
卤素含量Cl取代
含氮原子数2
含硫原子数2

相关专利 Related Patents

  1. 发明人王建平，唐晓军，钱学锋. "一种胱胺 二盐酸盐的合成方法" [P]. 中国发明专利, 专利号 CN 117556966 A, 授权公告日 2025-04-24.
  2. 发明人孙丽萍，唐晓军，陈志强. "Method for the Synthesis of 56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl) disulfide dihydrochloride Cystamin dihydrochloride Cystamine hydrochloride 2,2'-Dithio-bis-(ethylamine) dihydrochloride EINECS 200-260-7 NSC 39322 USAF CB-34 Cystamine HCl UNII-I90T518457" [P]. 中国发明专利, 专利号 CN 113526273 A, 授权公告日 2024-07-26.
  3. 发明人韩伟，王建平，沈红梅. "A Process for Preparing High-Purity 56-17-7 I90T518457 Cystamine dihydrochloride 2,2'-Dithiodi(ethylammonium) dichloride Ethylamine, 2,2'-dithiobis-, dihydrochloride Ethanamine, 2,2'-dithiobis-, hydrochloride (1:2) Ethanamine, 2,2'-dithiobis-, dihydrochloride AED 2-Aminoethyl disulfide dihydrochloride Bis(2-aminoethyl) disulfide dihydrochloride Cystamin dihydrochloride Cystamine hydrochloride 2,2'-Dithio-bis-(ethylamine) dihydrochloride EINECS 200-260-7 NSC 39322 USAF CB-34 Cystamine HCl UNII-I90T518457" [P]. 中国发明专利, 专利号 CN 109254028 A, 授权公告日 2015-05-18.

参考文献 Literature

  1. Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 胱胺 二盐酸盐 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2025, 2279, (6), 6319-6333.
  2. Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 胱胺 二盐酸盐 as an Impurity". Molecules, 2018, 87, (2), 9894-9908.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...